Evidence map›Paper›PMID 38203467›Full record

ReviewInternational journal of molecular sciences2023

Nanoparticle-Mediated Hyperthermia and Cytotoxicity Mechanisms in Cancer.

Vanessa-Meletia Bala, Dimitra Ioanna Lampropoulou, Stamatiki Grammatikaki, Vassilios Kouloulias, Nefeli Lagopati, Gerasimos Aravantinos, Maria Gazouli

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vanessa-Meletia BalaHygeia Hospital, Erithrou Stavrou 4, 15123 Marousi, Greece.ORCID 0000-0003-1423-2489
Dimitra Ioanna LampropoulouECONCARE, Chatzigianni Mexi 5, 11528 Athens, Greece.ORCID 0000-0003-3696-8550
Stamatiki GrammatikakiLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vassilios KoulouliasRadiation Oncology Unit, 2nd Department of Radiology, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-2082-7323
Nefeli LagopatiLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-9317-9510
Gerasimos AravantinosEuroclinic, Athanasiadou 7-9, 11521 Athens, Greece.
Maria GazouliLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-3295-6811

Funding

Hellenic Society of Medical Oncology 8953
6 · The paper itself

Abstract

Hyperthermia has the potential to damage cancerous tissue by increasing the body temperature. However, targeting cancer cells whilst protecting the surrounding tissues is often challenging, especially when implemented in clinical practice. In this direction, there are data showing that the combination of nanotechnology and hyperthermia offers more successful penetration of nanoparticles in the tumor environment, thus allowing targeted hyperthermia in the region of interest. At the same time, unlike radiotherapy, the use of non-ionizing radiation makes hyperthermia an attractive therapeutic option. This review summarizes the existing literature regarding the use of hyperthermia and nanoparticles in cancer, with a focus on nanoparticle-induced cytotoxicity mechanisms.

Indexed as

Hyperthermia, InducedNanoparticlesNeoplasmsHumansHyperthermiacancercytotoxicity mechanismshyperthermiananoparticles

Identifiers

PMID38203467
PMCPMC10779099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.